Article
Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer.
Journal of cancer research and clinical oncology - 1 Apr 2012
Zhang Bo, Wang Kai, He Gang, Guan Xinying, Liu Botao, Liu Yangbo, Bai Yun
Abstract excerpt
PURPOSE: Peroxiredoxins, which reduced intracellular peroxides as a noval kind of antioxidant protein, were extensively expressed in various types of cancers and were thought as a biomarker of cancer cells. In this work, we performed genotyping analyses for tag SNP of Prdx 1, 2 and 6, and then evaluated the association with susceptibility and clinic stage of esophageal squamous cell carcinoma (ESCC) in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
